We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Continue >
go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Bristol-Myers Squibb Pharmaceutical Limited
Watery Lane, Swords, Co. Dublin,
Telephone: 1 800 749 749
Medical Information Direct Line: Freephone: 1 800 749 749
Medical Information e-mail: Medical.information@bms.com
Patient Information Leaflet last updated on medicines.ie: 02/03/2017
PIL Daklinza

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 02/03/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision
Updated on 18/01/2017 and displayed until 02/03/2017
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Company name change or merger
Updated on 28/06/2016 and displayed until 18/01/2017
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 29/01/2016 and displayed until 28/06/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 29/09/2015 and displayed until 29/01/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 10/09/2015 and displayed until 29/09/2015
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to side-effects
  • Change to date of revision
Updated on 26/06/2015 and displayed until 10/09/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to date of revision
Updated on 05/05/2015 and displayed until 26/06/2015
Reasons for adding or updating:
  • Change to date of revision
Updated on 14/11/2014 and displayed until 05/05/2015
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Daclatasvir dihydrochloride